Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.30
23.01.22
-
23.01.23
15.82%
06.02.22

Risky Investment
quelbe60 
23.01.22 50%
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€6.43
23.01.22
-
23.01.23
7.21%
06.02.22

Could be very worthwhile Investment >20% year
thomasw 
23.01.22 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€56.11
05.02.21
€90.00
05.02.22
-5.54%
05.02.22

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
mthimm 
05.02.21 80%
buy
Bayer AG

Start price
Target price
Perf. (%)
€56.11
05.02.21
€90.00
05.02.22
-5.54%
05.02.22

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
mthimm 
05.02.21 80%
buy
Epizyme Inc.

Start price
Target price
Perf. (%)
€1.10
27.01.22
€1.00
27.01.23
41.00%
05.02.22

Could be worthwhile Investment >10% per year
Capable Management
Bad culture
me8 
27.01.22 0%
buy
Bayer AG

Start price
Target price
Perf. (%)
€44.90
05.12.21
€57.00
05.12.22
18.68%
03.02.22

Mori8 
05.12.21 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€44.90
05.12.21
€57.00
05.12.22
18.68%
03.02.22

Mori8 
05.12.21 50%
buy
Innate Pharma

Start price
Target price
Perf. (%)
€4.12
10.01.22
-
10.01.23
-14.85%
01.02.22

Could be worthwhile Investment >10% per year
melinda 
10.01.22 0%
buy
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€6.41
20.12.21
€7.20
20.12.22
-15.91%
30.01.22

Standard Investments for future growth
Higher EBIT margin than peer group
Very low/no dividend yield expected
ROE lower than 10% per year
geldnutzer 
20.12.21 50%
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€125.18
28.05.21
€200.00
28.05.22
-35.69%
29.01.22

Top 10 in its market
Very Future proof/growth oriented business model
Leading role in innovation
Significant cyclical dependencies
jomobb 
28.05.21 80%
buy
Immuron

Start price
Target price
Perf. (%)
€2.96
14.01.22
€0.000
14.01.23
18.92%
28.01.22

Could be very worthwhile Investment >20% year
Higher EBIT margin than peer group
Undervalued
Low dividend yield expected
Ruckelsbuckel 
14.01.22 80%
buy
Supernus Pharmaceuticals

Start price
Target price
Perf. (%)
€25.20
25.01.21
€28.00
25.01.22
3.97%
26.01.22

Could be worthwhile Investment >10% per year
melinda 
25.01.21 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€463.95
25.01.21
€500.00
25.01.22
15.42%
26.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
WatchMen 
25.01.21 0%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€463.95
25.01.21
€500.00
25.01.22
15.42%
26.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
WatchMen 
25.01.21 0%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€463.95
25.01.21
€500.00
25.01.22
15.42%
26.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
WatchMen 
25.01.21 0%
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€23.62
15.10.21
-
18.01.25
-45.89%
24.01.22

Could be worthwhile Investment >10% per year
Very high cyclical dependencies
Gilbert 
15.10.21 0%
buy
Eledon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€13.36
23.01.21
€100.00
23.01.22
-77.10%
24.01.22

Could be very worthwhile Investment >20% year
Maxi_Scalibusa 
23.01.21 50%
buy
Advaxis Inc.

Start price
Target price
Perf. (%)
€0.62
23.01.21
€60.00
23.01.22
-81.94%
24.01.22

Could be very worthwhile Investment >20% year
Maxi_Scalibusa 
23.01.21 50%
buy
Teligent Inc.

Start price
Target price
Perf. (%)
€0.99
23.01.21
-
23.01.22
-97.97%
24.01.22

Could be very worthwhile Investment >20% year
Maxi_Scalibusa 
23.01.21 0%
buy
Zosano Pharma Corp.

Start price
Target price
Perf. (%)
€31.33
23.01.21
-
23.01.22
-55.15%
24.01.22

Could be very worthwhile Investment >20% year
Maxi_Scalibusa 
23.01.21 0%
buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.86
23.01.21
€3.00
23.01.22
-38.46%
24.01.22

Could be very worthwhile Investment >20% year
Higher risks for its business
yester 
23.01.21 0%
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€3.02
09.01.22
-
09.01.23
-18.54%
23.01.22

Could be very worthwhile Investment >20% year
blaugold 
09.01.22 50%
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€37.69
13.01.22
-
13.01.23
-12.15%
23.01.22

Could be very worthwhile Investment >20% year
blaugold 
13.01.22 50%
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€17.60
10.01.22
-
10.01.23
-27.39%
23.01.22

Risky Investment
thomasw 
10.01.22 50%
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€3.71
09.01.22
-
09.01.23
-11.02%
22.01.22

Could be worthwhile Investment >10% per year
bundfuture 
09.01.22 50%